| APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease A Parsa, WHL Kao, D Xie, BC Astor, M Li, C Hsu, HI Feldman, RS Parekh, ... New England Journal of Medicine 369 (23), 2183-2196, 2013 | 770 | 2013 |
| The gut microbiome, kidney disease, and targeted interventions A Ramezani, DS Raj Journal of the American Society of Nephrology 25 (4), 657-670, 2014 | 765 | 2014 |
| Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC J Gupta, N Mitra, PA Kanetsky, J Devaney, MR Wing, M Reilly, VO Shah, ... Clinical journal of the American Society of Nephrology 7 (12), 1938-1946, 2012 | 612 | 2012 |
| Fibroblast growth factor-23 and cardiovascular events in CKD JJ Scialla, H Xie, M Rahman, AH Anderson, T Isakova, A Ojo, X Zhang, ... Journal of the American Society of Nephrology 25 (2), 349-360, 2014 | 544 | 2014 |
| Nocturnal hemodialysis: three-year experience. A Pierratos, M Ouwendyk, R Francoeur, S Vas, DS Raj, AM Ecclestone, ... Journal of the American Society of Nephrology 9 (5), 859-868, 1998 | 506 | 1998 |
| Trimethylamine N-Oxide: The Good, the Bad and the Unknown MT Velasquez, A Ramezani, A Manal, DS Raj Toxins 8 (11), 326, 2016 | 450 | 2016 |
| Advanced glycation end products: a Nephrologist's perspective DSC Raj, D Choudhury, TC Welbourne, M Levi American journal of kidney diseases 35 (3), 365-380, 2000 | 441 | 2000 |
| Inflammation and progression of CKD: the CRIC study RL Amdur, HI Feldman, J Gupta, W Yang, P Kanetsky, M Shlipak, ... Clinical journal of the American Society of Nephrology 11 (9), 1546-1556, 2016 | 413 | 2016 |
| Role of the gut microbiome in uremia: a potential therapeutic target A Ramezani, ZA Massy, B Meijers, P Evenepoel, R Vanholder, DS Raj American Journal of Kidney Diseases 67 (3), 483-498, 2016 | 369 | 2016 |
| Wasting in chronic kidney disease RH Mak, AT Ikizler, CP Kovesdy, DS Raj, P Stenvinkel, K Kalantar-Zadeh Journal of cachexia, sarcopenia and muscle 2 (1), 9-25, 2011 | 347 | 2011 |
| Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease J Chen, MJ Budoff, MP Reilly, W Yang, SE Rosas, M Rahman, X Zhang, ... JAMA cardiology 2 (6), 635-643, 2017 | 339 | 2017 |
| IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial PM Ridker, M Devalaraja, FMM Baeres, MDM Engelmann, GK Hovingh, ... The Lancet 397 (10289), 2060-2069, 2021 | 337 | 2021 |
| Fibroblast growth factor 23 and Inflammation in CKD JM Mendoza, T Isakova, AC Ricardo, H Xie, SD Navaneethan, ... Clinical Journal of the American Society of Nephrology 7 (7), 1155-1162, 2012 | 316 | 2012 |
| Diets and enteral supplements for improving outcomes in chronic kidney disease K Kalantar-Zadeh, NJ Cano, K Budde, C Chazot, CP Kovesdy, RH Mak, ... Nature Reviews Nephrology 7 (7), 369-384, 2011 | 275 | 2011 |
| Gut microbiome in chronic kidney disease: challenges and opportunities A Nallu, S Sharma, A Ramezani, J Muralidharan, D Raj Translational Research 179, 24-37, 2017 | 256 | 2017 |
| Role of interleukin-6 in the anemia of chronic disease DSC Raj Seminars in arthritis and rheumatism 38 (5), 382-388, 2009 | 253 | 2009 |
| Gut microbiota in hypertension PA Jose, D Raj Current opinion in nephrology and hypertension 24 (5), 403-409, 2015 | 211 | 2015 |
| β 2-Microglobulin kinetics in nocturnal haemodialysis DSC Raj, M Ouwendyk, R Francoeur, A Pierratos Nephrology Dialysis Transplantation 15 (1), 58-64, 2000 | 197 | 2000 |
| Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin DSC Raj, B Vincent, K Simpson, E Sato, KL Jones, TC Welbourne, M Levi, ... Kidney international 61 (2), 697-704, 2002 | 189 | 2002 |
| Relation of serum lipids and lipoproteins with progression of CKD: the CRIC study M Rahman, W Yang, S Akkina, A Alper, AH Anderson, LJ Appel, J He, ... Clinical journal of the American Society of Nephrology 9 (7), 1190-1198, 2014 | 166 | 2014 |
